N4 Pharma Plc is a UK-based specialist pharmaceutical company that focuses on the development of a silica nanoparticle delivery system for pharmaceutical and biotech companies. Its flagship product, Nuvec, is a non-viral adjuvant delivery system that is designed to enhance the efficacy of vaccines and cancer treatments. The company has a research partnership with Nanomerics Limited to develop different formulations of Nuvec. N4 Pharma was founded in 1979 and is headquartered in London, UK.
N4 Pharma Plc 's ticker is N4P
The company's shares trade on the LSE stock exchange
They are based in London, England
There are 1-10 employees working at N4 Pharma Plc
It is https://www.n4pharma.com/
N4 Pharma Plc is in the Healthcare sector
N4 Pharma Plc is in the Drug Manufacturers - Other industry
The following five companies are N4 Pharma Plc 's industry peers: